Last viewed: MRTX


Prices are updated after-hours



nasdaq:MRTX Mirati Therapeutics, Inc.

MRTX | $118.45 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-13.0% 1m) (-45.2% 1y) (-2.1% 2d) (-3.4% 3d) (-4.9% 7d) (NaN% volume)
http://www.mirati.com
Sec Filling | Patents | 111 employees

Mirati Therapeutics, Inc. is a clinical-stage oncology company. The firm engages in developing a pipeline of oncology products to treat genetic, immunological and epigenetic drivers of cancer in subsets of cancer patients. Its clinical pipeline consists of glesatinib, sitravatinib and mocetinostat. The company was founded on December 13, 1995 and is headquartered in San Diego, CA.

add to today's watch list email alert is off




cancer   immunology   genetic  

Press-releases


BioSpace Movers & Shakers, Jan. 14
Published: 2022-01-14 (Crawled : 13:30) - biospace.com/
LLY | $250.28 | twitter stocktwits trandingview |
Health Technology
| | O: -1.46% H: 0.0% C: 0.0%
AMRX | $4.61 | twitter stocktwits trandingview |
Health Technology
| | O: -1.71% H: 0.0% C: 0.0%
MRTX | $118.45 | twitter stocktwits trandingview |
Health Technology
| | O: -2.14% H: 0.0% C: 0.0%
GILD | $71.91 | twitter stocktwits trandingview |
Health Technology
| | O: -0.32% H: 0.0% C: 0.0%
GLAXF | $22.9 | twitter stocktwits trandingview |
Health Technology
| | O: -1.67% H: 3.62% C: 3.62%
PPG | $165.915 | twitter stocktwits trandingview |
Process Industries
| | O: -2.07% H: 0.0% C: 0.0%
AMGN | $230.86 | twitter stocktwits trandingview |
Health Technology
| | O: -0.53% H: 0.0% C: 0.0%
PHAT | $14.8 | twitter stocktwits trandingview |
Health Technology
| | O: -3.08% H: 0.0% C: 0.0%
JNJ | News | $168.61 | twitter stocktwits trandingview |
Health Technology
| | O: -0.53% H: 0.0% C: 0.0%
GSK | $45.29 | twitter stocktwits trandingview |
Health Technology
| | O: -0.35% H: 0.0% C: 0.0%

space spac
Investigation Alert: Did You Lose Money on Your Stock? Johnson Fistel, LLP Encourages Investors to Contact the Firm
Published: 2021-12-29 (Crawled : 01:00) - prnewswire.com
ABSI | $6.74 | twitter stocktwits trandingview |
| | O: 0.76% H: 18.25% C: 8.31%
PRPL | $10.42 | twitter stocktwits trandingview |
Miscellaneous
| | O: 0.68% H: 2.47% C: -0.3%
SEER | $19.59 | twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 0.6% H: 8.62% C: 4.12%
ROL | $32.61 | twitter stocktwits trandingview |
Consumer Services
| | O: -0.3% H: 0.96% C: 0.57%
OSH | $23.15 | twitter stocktwits trandingview |
Health Services
| | O: 0.65% H: 4.92% C: 3.33%
MRTX | $118.45 | twitter stocktwits trandingview |
Health Technology
| | O: -0.15% H: 3.53% C: 2.94%
FCFS | $73.85 | twitter stocktwits trandingview |
Finance
| | O: 0.04% H: 2.59% C: 1.98%


Artificial Intelligence Being Used to Accurately Predict Synergistic Cancer Drug Combinations
Published: 2021-12-10 (Crawled : 19:00) - prnewswire.com
BMY | $64.93 | twitter stocktwits trandingview |
Health Technology

MRTX | $118.45 | twitter stocktwits trandingview |
Health Technology

AMGN | $230.86 | twitter stocktwits trandingview |
Health Technology

ONCY | $1.55 | twitter stocktwits trandingview |
Health Technology

MRK | $81.38 | twitter stocktwits trandingview |
Health Technology

artificial intelligence drug cancer drug cancer
BeiGene to Present New Clinical Data on Tislelizumab at ESMO IO Congress 2021
Published: 2021-12-02 (Crawled : 09:00) - biospace.com/
MRTX | $118.45 | twitter stocktwits trandingview |
Health Technology
| | O: -5.18% H: 4.5% C: 4.05%


Mirati Therapeutics to Participate in the 4th Annual Evercore ISI HealthCONx Conference
Published: 2021-11-23 (Crawled : 22:00) - prnewswire.com
MRTX | $118.45 | twitter stocktwits trandingview |
Health Technology
| | O: -0.96% H: 3.58% C: 3.45%

conference therapeutics
Mirati Therapeutics Announces Submission of Investigational New Drug Application to U.S. Food and Drug Administration of MRTX1719 to Treat MTAP-Deleted Cancers
Published: 2021-11-17 (Crawled : 13:00) - biospace.com/
MRTX | $118.45 | twitter stocktwits trandingview |
Health Technology
| | O: 1.02% H: 0.86% C: -1.77%

new drug food application cancer drug submission
Mirati Therapeutics Announces Pricing of Public Offering of Common Stock - Nov 11, 2021
Published: 2021-11-11 (Crawled : 10:00) - biospace.com/
MRTX | $118.45 | twitter stocktwits trandingview |
Health Technology
| | O: -9.87% H: 2.2% C: -0.62%

offering
Mirati Therapeutics to Participate in the Stifel 2021 Virtual Healthcare Conference
Published: 2021-11-09 (Crawled : 14:15) - biospace.com/
MRTX | $118.45 | twitter stocktwits trandingview |
Health Technology
| | O: 8.81% H: 0.86% C: -3.54%

conference
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mirati Therapeutics, Inc. - MRTX
Published: 2021-11-04 (Crawled : 09:00) - prnewswire.com
MRTX | $118.45 | twitter stocktwits trandingview |
Health Technology
| | O: 5.67% H: 0.79% C: -2.33%


Mirati Therapeutics to Report Financial Results for Third Quarter 2021 and Recent Corporate Updates on November 8, 2021
Published: 2021-11-01 (Crawled : 21:00) - prnewswire.com
SNY | News | $51.51 | twitter stocktwits trandingview |
Health Technology
| | O: 1.5% H: 0.35% C: -0.27%
MRTX | $118.45 | twitter stocktwits trandingview |
Health Technology
| | O: 0.39% H: 2.16% C: 1.92%

financial results results
See all


Last 15 days Sec forms
File Id Form Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Today's Insiders Buying

Yesterday's Insiders Buying